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Next-generation sequencing and other
high-throughput technologies have made
it feasible to characterize millions of
sequence variations on large numbers of
study participants. But when it comes to
identifying a small number of these genetic
features (or feature sets) that are associated
with a disease trait, the investigator is faced
with a formidable multiple-testing chal-
lenge. It can be thought of as a signal-to-
noise problem, where the large number of
unrelated genetic features tends to drown
out the faint signal of the small number of
biologically relevant features.
The theoretical underpinnings of an
emerging class of statistical methods for
genomic studies, two-stage procedures for
both gene-gene and gene-environment
interactions have recently been described
in a remarkable article (Dai et al., 2012).
The key idea is that dimensionality of mul-
tiple testing in genomics can be reduced
by screening features to be tested with
an independent statistic in the same
dataset, thereby mitigating the multiple-
testing problem and increasing power to
detect effects. In other words, the noise is
reduced, allowing the relevant signal to be
more easily detected. These methods will
likely gain importance as high-throughput
technologies continue to yield exponen-
tially increasing amounts of information
per sample and per research dollar spent.
Dai et al. couched their paper in the
context of gene-environment interactions
only. However, it is worth noting that
the theoretical properties detailed by Dai
et al. apply not just to the search for
gene-environment interactions (GxE), but
also to (epistatic) interactions between
genetic variants (GxG), since in construct-
ing these hypothesis tests, both “gene”
and “environment” features are treated
analogously as discrete or continuous
variables in models designed to identify
associations with a disease trait. A notable
exception is when the approach depends
on the environmental exposure being a
randomized treatment, allowingadditional
assumptions to be made.
One such screening-testing interaction
approach is designed for a case-control
study where the investigator is interested
in identifyingGxGorGxE pairs involved in
interactions (Millstein et al., 2006;Murcray
et al., 2009; Dai et al., 2012; Lewinger
et al., 2013). There is an assumption that
each pair of features considered is indepen-
dent in the general population, and only
if a dependence is found in the pooled
case-control sample (the screening stage),
is the pair tested in a formal model that
includes an interaction term (the testing
stage), e.g., logit(P[D]) = α+ β1∗SNP1 +
β2
∗SNP2 + β3∗SNP1∗SNP2, where β3 is
the interaction parameter and D indicates
disease. The interaction parameter can be
testedaloneorinamultidegree-of-freedom
testofoneorbothmaineffectstogetherwith
the interaction, an approach that was gen-
erally found to bemore powerful (Millstein
et al., 2006; Kraft et al., 2007). An impor-
tant characteristic of the approach is that
even if the independence assumption is not
justified, type I error in the testing stage
will still be properly controlled.
This approach is perhaps more general
and more powerful than previously appre-
ciated. The screening procedure appears to
be sensitive to both main effects and inter-
actions, not just interactions, as claimed
in prior work. The implication is that the
approach is less specific to interactions
and correspondingly more powerful when
main effects are present. In fact, it may
be capable of detecting weak interactions
coupled with weak main effects. Some
authors (Murcray et al., 2009; Dai et al.,
2012; Lewinger et al., 2013) have attributed
the statistical power of the screening pro-
cedure solely to an association in cases due
to an interaction in the underlying popu-
lation (non-zero β3, or more correctly, a
departure from multiplicativity on a rela-
tive risk scale), as in the case-only inter-
action analysis (Piegorsch et al., 1994).
According to this view, controls only con-
tribute noise to the screening procedure
because the factors are independent in this
population. Further, if the two features
contribute marginal disease risks and a
multiplicative relative risk model describes
their joint risk, then dependencies will
not be induced among cases. The idea is
that if there is independence in cases and
independence in controls, then it should
follow that there would be independence
in the pooled case-control sample—but
this is not necessarily the case. It has not
been adequately appreciated that when
cases and controls are pooled, main effects
can contribute a substantial increase in
power to capture disease-related feature
pairs with the above screening procedure.
Interestingly, the complex conditioning on
disease status inherent in pooling of cases
and controls can induce dependencies and
thus increase power of the screening pro-
cedure when main effects are present.
As proof of concept, consider the
relatively simple relative risk model,
log(P[D]) = λ+ β1∗SNP1 + β2∗SNP2 +
β3
∗SNP1∗SNP2, where exp (λ) is the
baseline risk, the two SNPs have equal
relative risks per allele, i.e., β1 = β2, there
is a weak interaction (small β3), and equal
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numbers of cases and controls sampled for
a moderately rare disease. It is apparent
that power to identify the disease related
SNPs using a screening approach based on
composite LD in the pooled case-control
sample can increase with the strength of
the main effects and be quite powerful
despite a weak interaction (Figure 1). This
result may explain why using the pooled
cases and controls generated a more effec-
tive screening tool than cases only, in an
application to identify SNPs that modify
estrogen treatment efficacy in theWoman’s
Health Initiative study (Dai et al., 2012).
It is up to future studies to clarify just
how much and under what conditions
main effects and controls contribute to the
power of the approach.
Dai et al. made a major contribution to
screening-testing designs by providing rig-
orous proofs that (1) screening-testing
approaches are valid if independent
statistics are used for the screening and
testing stages, and (2) various pairs of
statistics are independent. However, there
is general way to conceptualize some of
FIGURE 1 | Power in cases, controls, and a pooled case-control sample for a screening
procedure based on LD between SNPs. Empirical power calculations were plotted for detection
of composite LD between two SNPs, independent in the general population, coded additively in the
number of minor alleles, with minor allele frequencies of 0.2. Detection of composite LD was
performed by applying the t-distribution to Pearson’s product moment correlation coefficient with
α = 0.05. A population of 40000 individuals including a binary disease trait was simulated according
to the model, log(P[D]) = λ+ β1∗SNP1 + β2∗SNP2 + β3∗SNP1∗SNP2, where baseline risk of
disease was 5%, main effects were equal, β1 = β2, and the interaction was weak exp(β3) = 1.1.
Power of the screening procedure as described above is plotted over a range of main effect relative
risks [main effects RR = exp(β1) = exp(β2)] for a sample of 1000 cases only, 1000 controls only, and
a pooled case-control sample of 1000 cases and 1000 controls randomly sampled from the
population.
these approaches that leads to an intuitive
understanding of conditions that preserve
type I error, thus allowing investigators
to develop novel and complex screening-
testing approaches without having to
develop new proofs. In the types of stud-
ies under discussion, the ultimate objec-
tive is often to detect some form of asso-
ciation between the genetic features and
the disease trait, conditional on the ascer-
tainment scheme, that is, to find evi-
dence of associations in the study sam-
ple that reflect dependencies in the gen-
eral population. Thus, the corresponding
null hypotheses consist of some form of
independence between features of interest
and the disease trait both in the underly-
ing population and conditional on ascer-
tainment. If we define the global null
hypothesis to be independence between
the feature vector and the disease trait,
then any function of the features is also
independent of the disease trait under the
null, due to basic properties of indepen-
dence of random variables (Cassella and
Berger, 2002). Therefore, if a screening
statistic is strictly a function of the genetic
variables and does not depend on dis-
ease status, then the global null is equally
valid for the reduced set of variables, and
only the reduced set of tests needs to
be considered for multiple testing cor-
rection. Millstein et al. (2006) used this
rational to justify the screening-testing
approach described above. Also, Millstein
and Gauderman (2002) proposed a related
screening-testing approach for identify-
ing multi-SNP interactions in case-control
studies that involved estimation of an ana-
lytically intractable parameter. The screen-
ing statistic was based on the density of
the most dense multi-locus genotype clus-
ters in the pooled case-control sample.
However, it was intuitively clear to the
authors (and demonstrated empirically)
that proper control of type I error was
achieved by the approach, because the
screening procedure did not depend on
disease status in any way (aside from being
conditional on ascertainment).
Screening-testing interaction
approaches have the potential to be
applied across a broad array of study
designs, and have already branched out
beyond the original case-control appli-
cation. For instance, there have been
applications for studies of nuclear fam-
ilies (Millstein et al., 2005) and trios
(Gauderman et al., 2010) as well as sur-
vival analysis (Dai et al., 2012). But there
are many other potential applications that
have not yet been proposed. For instance,
there are many studies that are designed to
investigate traits within a diseased popu-
lation, such as response to treatment, age
of onset, or disease progression. It is easy
to envision a scenario where features that
interact to confer risk of disease also inter-
act to affect disease traits. It would seem
that a powerful screening-testing approach
for this scenario would be analogous to the
approach described above, that is, identify
feature pairs with evidence of unexpected
dependencies (screening), and then test
them for joint effects on disease traits
(testing). Proper type I error control in the
testing stage is preserved under the null of
independence between the features and the
disease traits. For example, if we are con-
ducting a study of obese patients, we could
perform the screening procedure using all
of these patients, looking for dependen-
cies between features (G-G or G-E) that
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we expect to be independent in the gen-
eral population, effectively conducting a
case-only interaction analysis but without
requiring statistical significance. Then in
the testing stage the top feature pairs from
the screening procedure would be tested
for joint effects on BMI as a continuous
outcome in a linear model using data from
the same obese study participants. The
Bonferroni correction would only need to
account for the number of tests that were
conducted in the testing stage.
Screening-testing interaction
approaches could have even broader
applications if we are able to relax the
assumption of independence between the
screening and testing statistics. The meth-
ods could then be applied to other designs,
such as cross-sectional and cohort stud-
ies. For example, suppose we think that
some pair of features may jointly affect
disease, having both main effects and
interactions. We may want to screen on
the interaction effect but jointly test main
effects and interactions in the testing stage,
since joint tests can be much more pow-
erful (Millstein et al., 2006; Kraft et al.,
2007) and to avoid missing an impor-
tant discovery if in truth there is a strong
interaction but weak or non-existent main
effects. Clearly, in this case we would not
have independence between the screen-
ing and testing statistics. However, GWAS
analyses are often conducted under the
assumption of exchangeability of obser-
vations under the null. And under the
assumption of exchangeability, one can
often construct a permutation procedure
to control family-wise type I error or esti-
mate FDR, even when the distribution
of the test statistic is not known or not
accurate. Such an approach may seem
computationally infeasible for a genome-
wide application, but very fast epistasis
screening procedures have recently been
developed (Kam-Thong et al., 2011),
and it is demonstrated elsewhere in this
issue that accurate estimates of FDR can
be generated with as few as 10 permu-
tations (Millstein and Volfson, 2013).
Thus, under the assumptions of exchange-
ability and independence between the
features and the disease trait under the
null, the above screening-testing approach
or related approaches could be applied
and FDR estimated, even when relatively
few permutations are conducted. The
Millstein and Volfson approach includes
a confidence interval estimator for FDR
that accounts for the number of permu-
tations conducted, thereby quantifying
uncertainty, which is especially useful in
the presence of weak effects and small
numbers of permutations.
Given the breadth of previously pro-
posed applications as well as potential new
directions and insights discussed here, it
seems likely that the use of screening-
testing interaction approaches will prove
to have a big impact on future identifica-
tion of multi-locus as well as GxE effects.
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